News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

MEDIAN Technologies Joins Forces with Quintiles to Provide World-Class Clinical Trial Imaging Services



2/16/2012 11:01:19 AM

SOPHIA ANTIPOLIS, France--(BUSINESS WIRE)--To improve the assessment of how cancer patients are responding to investigational therapies in clinical trials, MEDIAN Technologies (Paris:ALMDT)(ALMDT) today announced a strategic agreement with Quintiles to offer advanced integrated image services to biopharmaceutical customers worldwide.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES